Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Avelumab Chemical Structure
BCP25212 Avelumab 1537032-82-8
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Durvalumab Chemical Structure
BCP25841 Durvalumab 1428935-60-7
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules.
Pembrolizumab Chemical Structure
BCP24244 Pembrolizumab 1374853-91-4
Pembrolizumab (formerly MK-3475 and lambrolizumab) is a humanized antibody used in cancer immunotherapy. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells, and allows the immune system to destroy those cancer cells. It targets the programmed cell death 1 (PD-1) receptor of lymphocytes.
Ramucirumab Chemical Structure
BCP29228 Ramucirumab 947687-13-0
Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.It is directed against the vascular endothelial growth factor receptor 2 (VEGFR2).
Eculizumab Chemical Structure
BCP26255 Eculizumab 219685-50-4
Eculizumab is a humanized monoclonal antibody functioning as a terminal complement inhibitor.
Eylea Chemical Structure
BCP29058 Eylea 845771-78-0
Aflibercept is an inhibitor of vascular endothelial growth factor (VEGF).
Rituximab Chemical Structure
BCP20918 Rituximab 174722-31-7
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells.
Avastin Chemical Structure
BCP07998 Avastin 216974-75-3
Denosumab Chemical Structure
BCP05825 Denosumab 615258-40-7
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Trastuzumab Chemical Structure
BCP05130 Trastuzumab 180288-69-1
Trastuzumab is a monoclonal antibody used to treat breast cancer.
123下一页共 30 条记录 1 / 3 页